Refractory atypical IgA pemphigus successfully treated with apremilast

J Dermatol. 2024 Mar;51(3):e86-e87. doi: 10.1111/1346-8138.17007. Epub 2023 Oct 21.

Authors

Yuxi Zhou¹, Yue Xiao¹, Yiyi Wang¹, Wei Li¹

Affiliation

¹ Department of Dermatology & Venerology, Rare Diseases Center, Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

PMID: 37864455
DOI: 10.1111/1346-8138.17007

No abstract available

Publication types

Letter

MeSH terms

Autoantibodies
Humans
Immunoglobulin A
Pemphigus* / diagnosis
Pemphigus* / drug therapy
Thalidomide / analogs & derivatives*
Thalidomide / therapeutic use

Substances

apremilast
Autoantibodies
Thalidomide
Immunoglobulin A

Grants and funding

ZYJC21050/West China Hospital, Sichuan University